• Home
  • Find a Pharmacy
  • Health News
  • Medications
  • Conditions
  • RxCoupons
  • Pharmacy Solutions
RxWiki - Home
Find a Pharmacy Health News Medications Conditions RxCoupons Pharmacy Solutions

Neuromuscular DiseaseInfo Center

Reviewing the Options for Treating MS
Multiple sclerosis (MS) symptoms vary widely among those with the disease. And that can complicate efforts to prescribe the right treatment for MS patients.
TB Vaccine May Help Prevent MS
Multiple sclerosis (MS) is a tricky disease that’s sometimes difficult to diagnose. Researchers investigated if a vaccine might be helpful in stalling the disease in people who showed signs of MS.
No Added Benefit From MS Medications
While there is no cure for multiple sclerosis (MS), there are medications to manage the disease. Two of these medications work fairly well to control flare-ups. Could they work even better when combined?
The Cost of MS
There is no denying that healthcare in the U.S. has become expensive. For some multiple sclerosis (MS) patients, the cost of new drugs may not be worth the price.

REFINE

  • medications
      • (-) Remove Avonex filter Avonex
      • Copaxone (3) Apply Copaxone filter
      • Rebif (2) Apply Rebif filter
      • Aubagio (1) Apply Aubagio filter
      • Gilenya (1) Apply Gilenya filter
      • Imuran (1) Apply Imuran filter
      • Novantrone (1) Apply Novantrone filter
      • Tecfidera (1) Apply Tecfidera filter
      • Tysabri (1) Apply Tysabri filter
All information on this site is provided "as-is" for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health. The use of any information on this site is solely at your own risk.
  • Find a Pharmacy
  • Health News
  • Medications
  • Conditions
  • RxCoupons
  • Mobile App
  • Pharmacy Solutions
  • Terms and Conditions
  • Privacy Policy
  • Contact
  • Home
    Facebook
  • Home
    Google Plus
  • Home
    Twitter
© 2020 Digital Pharmacist Inc.